Company Filing History:

5 out of 837

Johnson Matthey Public Limited Company

patents

4 out of 21

Pharm-eco Laboratories, Inc.

patents

1 out of 2

Johnson Matthey Pharmaceutical Materials, Inc.

patents

Years Active: 2001-2016

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9505792 - Forms of cidofovir (2016-11-29),

2. 8999958 - Forms of cidofovir (2015-04-07),

3. 7161042 - Protected diols for prostaglandin synthesis (2007-01-09),

4. 7141706 - Protected and unprotected triols for prostaglandin synthesis (2006-11-28),

5. 7109371 - Prostaglandin synthesis (2006-09-19),

6. 6677459 - Amino acid derivatives and methods of making the same (2004-01-13),

7. 6590106 - Amino acid derivatives and methods of making the same (2003-07-08),

8. 6479669 - Amino acid derivatives and methods of making the same (2002-11-12),

9. 6462221 - Synthesis of nitroalcohol diastereomers (2002-10-08),

10. 6268535 - Synthesis of 3-aryl-1-indanamines (2001-07-31),

Title: Jurjus Jurayj: Innovator in Pharmaceutical Chemistry

Introduction

Jurjus Jurayj is a notable inventor based in Acton, MA (US), recognized for his contributions to pharmaceutical chemistry. He holds a total of 10 patents, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

Among his latest patents, Jurjus has developed various forms of cidofovir. Cidofovir is obtained in different forms, including amorphous cidofovir, crystalline anhydrous cidofovir, crystalline cidofovir monohydrate, and crystalline cidofovir dihydrate, including various polymorphs. These advancements are significant in the field of antiviral medications.

Career Highlights

Throughout his career, Jurjus has worked with prominent companies such as Johnson Matthey Public Limited Company and Pharm-Eco Laboratories, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.

Collaborations

Jurjus has collaborated with esteemed colleagues, including Richard L. Gabriel and Derek Wyndham Clissold. These partnerships have fostered a collaborative environment that enhances the quality of research and development in his field.

Conclusion

Jurjus Jurayj's work in pharmaceutical chemistry and his numerous patents reflect his commitment to innovation and improving healthcare solutions. His contributions continue to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com